HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Luc Girardet Selected Research

VRX-480773

2/2007A novel nonnucleoside analogue that inhibits human immunodeficiency virus type 1 isolates resistant to current nonnucleoside reverse transcriptase inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Luc Girardet Research Topics

Disease

4Gout
01/2019 - 10/2016
2Hyperuricemia
01/2018 - 10/2016
1Infections
02/2007
1HIV Infections (HIV Infection)
02/2007
1Hepatitis C
02/2006

Drug/Important Bio-Agent (IBA)

4Uric Acid (Urate)IBA
01/2019 - 10/2016
3lesinuradIBA
01/2019 - 10/2016
1verinuradIBA
01/2018
1Pharmaceutical PreparationsIBA
10/2016
1urate transporterIBA
10/2016
1Probenecid (Benemid)FDA LinkGeneric
10/2016
1BenzbromaroneIBA
10/2016
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
02/2007
1VRX-480773IBA
02/2007
15-cyanouracilIBA
02/2006
1RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA
02/2006

Therapy/Procedure

2Therapeutics
10/2016 - 02/2007